Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2025-06-23
2025-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
12-Week Study on the Efficacy of Two Serums in Improving Skin Aging and Tone
NCT07156071
Cream Short-term Efficacy Clinical Study
NCT07067086
12-Week Efficacy Clinical Study of Serum
NCT06968416
ANTI-DYNAMIC LINE Test for Cream
NCT07067073
Serum Instant Anti-Redness Efficacy Clinical Study
NCT07058701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Serum Application Regimen
Facial serum application
Dosage on face: About 0.5g/face for serum.
Combination Regimen
HA injection
Using vacuum negative pressure technology, hyaluronic acid and other moisturizing nutrients are directly injected into the deep skin, effectively improving dermal dehydration and dryness from the muscle base, so that the skin can quickly replenish water.
Facial serum application
Dosage on face: About 0.5g/face for serum.
Injection-Exclusive Regimen
HA injection
Using vacuum negative pressure technology, hyaluronic acid and other moisturizing nutrients are directly injected into the deep skin, effectively improving dermal dehydration and dryness from the muscle base, so that the skin can quickly replenish water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HA injection
Using vacuum negative pressure technology, hyaluronic acid and other moisturizing nutrients are directly injected into the deep skin, effectively improving dermal dehydration and dryness from the muscle base, so that the skin can quickly replenish water.
Facial serum application
Dosage on face: About 0.5g/face for serum.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. All skin types by subjects' self-perceived.
3. Willing to perform HA injection.
4. Did not perform any of the beauty procedure projects in the past 6 months.
5. Lack of hydration, radiance, brightness, smoothness, firmness and elasticity by self-claimed.
6. Presenting with corresponding severity for the attribute evaluated by Dermatologist included:
* Radiance, smoothness, elasticity, cheek plumpness and firmness: 3≤grade≤6.
* Global fine lines: 3≤grade.
* Underneath eye wrinkles: 2≤grade≤5.
* Forehead wrinkles: 1\<grade≤4.
* Glabella wrinkles: 1\<grade.
7. All accept not to use any cosmetics, skincare products, beauty equipment, all topical medications and cleansing products on face at visit days.
8. Did not participate any clinical test or cosmetic product test on skin within 1 months.
9. No disagreement of dermatologist because of other reasons that exclude the participation of the volunteer.
10. In general, good health at the time of the study.
11. Willing and able to participate as evidenced by signing of informed consent \& photo release form.
12. Must be willing to comply with all study protocol requirements.
Exclusion Criteria
2. Subject deprived of rights by a court or administrative order.
3. Major subject to a guardianship order.
4. Subject residing in a health or social care establishment.
5. Patient in an emergency setting.
6. Subject with a skin disease in the test areas as well as skin allergy (particularly e.g., acne, rosacea, eczema).
7. Subject presenting a stable or progressive serious disease (per investigator's assessment).
8. Immuno-compromised subject.
9. Subject with history of allergy to cosmetic or personal care products or ingredients.
10. Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment).
11. Subject with history of sunlight sensitivity or allergies.
12. Subject regularly practicing aquatic or nautical sports.
13. Subject regularly attending a sauna.
14. Subject with physical highly sensitive constitution.
15. Subject with cardiovascular or circulatory history.
16. Subject with a history of skin cancer or malignant melanoma.
17. Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune-suppressants in the last 6 months before study.
25 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ChinaNorm
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai China-norm Quality Technical Service Co., Ltd.
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C25005046
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.